Global Pharmaceutical Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry

1
Global Pharmaceutical Survey 2013-2014 - Market
Trends, Buyer Spend  

• Bharat Book Bureau

2
Summary

• Product SynopsisGlobal Pharmaceutical Survey
  20132014 Market Trends, Buyer Spend and
  Procurement Strategies in the Global
  Pharmaceutical Industry is a new report by ICD
  Research that analyzes how pharmaceutical
  industry companies procurement expenditures,
  business strategies, and practices are set to
  change in 20132014. Additionally, this report
  also presents comparative analysis between four
  years of survey results (wherever applicable).
  This report gives access to category-level
  spending outlooks, budgets, supplier selection
  criteria, business challenges, and investment
  opportunities of leading purchase decision
  makers. The report also identifies the future
  growth of buyers and suppliers, MA, capital
  expenditure, staff hiring, and e-procurement.
  This report not only grants access to the
  opinions and strategies of business decision
  makers and competitors, but also examines their
  actions surrounding business priorities, as well
  as access to information categorized by region,
  company type, and size. 

3
Continue

• Introduction and LandscapeWhy was the report
  written?This report is the result of an
  extensive survey drawn from ICD Researchs
  exclusive panel of leading global pharmaceutical
  industry executives it provides data and
  analysis on buyer expenditure, procurement, and
  developments within the global pharmaceutical
  industry. The report includes key topics such as
  global pharmaceutical industry buyer expenditure
  and procurement behaviours and strategies, and
  identifies the threats and opportunities within
  the global pharmaceutical industry, economic
  outlook trends, and business confidence within
  global pharmaceutical executives. Most secondary
  research reports are based on general industry
  drivers and do not understand the industry
  executives attitude and changing behaviours,
  creating a gap in presenting the business outlook
  of the industry in an effort to bridge this gap,
  ICD Research created this primary-research based
  report by gathering the opinions of multiple
  stakeholders in the value-chain of the global
  pharmaceutical industry.

4
Continue

• What is the current market landscape and
  what is changing?Executives from the global
  pharmaceutical industry anticipate an increase in
  levels of consolidation, with 61 of respondents
  projecting an increase in MA activities in
  2013.What are the key drivers behind recent
  market changes?The need for new product
  pipelines, new product acquisition, patent
  expiries, cost containment and credit
  availability have prompted companies to
  consolidate positions and look for merger and MA
  acquisition.

5
Continue

• What makes this report unique and essential to
  read?This report is the result of an extensive
  survey drawn from ICD Researchs exclusive panel
  of leading global pharmaceutical industry
  executives it provides data and analysis on
  buyer expenditure, procurement, and developments
  within the global pharmaceutical industry. The
  report includes key topics such as global
  pharmaceutical industry buyer expenditure and
  procurement behaviours and strategies, and
  identifies the threats and opportunities within
  the global pharmaceutical industry, economic
  outlook trends, and business confidence within
  global pharmaceutical industry executives.
  Additionally, this report also presents
  comparative analysis between four years of survey
  results (wherever applicable). 

6
Continue

• Key Features and BenefitsProject industry
  trends and revenue growth expectations in 2013,
  and understand business confidence to make
  informed business decisions.Drive revenues by
  understanding future product investment areas and
  key growth regions.Uncover key challenges and
  opportunities, and identify the key actions
  required to maintain and win buyer
  business.Formulate effective sales and marketing
  strategies by identifying how buyer budgets are
  changing and the direction of spending in the
  future. Better promote your business by aligning
  your capabilities and business practices with
  your customers changing needs Secure stronger
  customer relationships by understanding the
  behaviour and changing strategies of industry
  buyers. 

7
Continue

• Key Market IssuesChina, Brazil and India are
  the important emerging markets to offer growth in
  2013.Market uncertainty, responding to price
  pressure, rising competition and regulatory
  changes are the leading business concerns for
  the global pharmaceutical industry in
  2013.Overall, for 2013, the average size of the
  annual procurement budget for global
  pharmaceutical industry buyer respondents is
  projected at US127 million, against US127
  million in 2012 and US110 million in
  2011.Price, level of service and existing
  relationship with supplier are considered the
  most important factors for supplier selection in
  the global pharmaceutical industry, while
  environmental records and CSR, brand
  reputation and proximity of supplier
  operations are considered the least
  important.While 16 of buyer respondents from
  the global pharmaceutical industry are willing to
  implement e-procurement in 2013 or beyond, 32
  are already in the different stages of
  implementation (partially implemented,
  completely implemented, and evaluation or
  pilot use) 

8
Continue

• Key HighlightsAn analysis of revenue growth
  expectations by senior level respondents reveals
  that 62 are more optimistic about their
  companys revenue growth in 2013.A significant
  percentage of pharmaceutical manufacturing
  industry respondents highlighted that capital
  expenditure towards new product development,
  employee training, and IT infrastructure
  development would increase in 2013. The top
  three priorities for global pharmaceutical
  industry buyer respondents in 2013 are new
  products and services, improve operational
  efficiency and expand in current markets.A
  total of 49 of respondents from pharmaceutical
  manufacturing companies, 68 of respondents from
  CROs and CMOs companies, and 64 of respondents
  from pharmaceutical industry supplier companies
  anticipate an increase of their current workforce
  in 2013.Survey results show that respondents
  from the global pharmaceutical industry
  identified the US to offer the highest growth
  potential among developed countries in
  20132014.

9
Table of Contents

• 1. Introduction1.1 What is This Report
  About?1.2 Definitions1.3 Methodology1.4
  Profile of Survey Respondents Global
  Pharmaceutical Industry1.4.1 Global
  pharmaceutical industry profile of buyer
  respondents1.4.2 Global pharmaceutical industry
  profile of supplier respondents2 Executive
  Summary3 Global Pharmaceutical Industry
  Dynamics3.1 Revenue Growth Projections in the
  Global Pharmaceutical Industry3.1.1 Revenue
  growth projections by company type3.1.2 Revenue
  growth projections by region3.1.3 Revenue growth
  projections by company turnover

10
For More Information You Can Visit-

• http//www.bharatbook.com/healthcare-market-r
  esearch-reports/global-pharmaceutical-survey-2013-
  2014-market-trends-buyer-spend-and-procurement-str
  ategies-in-the-global-pharmaceutical-industry.html
  
• Or visit us at
• Bharat Book
  Bureau Phone
  91 22 27810772, 27810773
  Toll Free No for USA/Canada
  1-866-279-8368
  E-mail info_at_bharatbook.com
  Website www.bharatbook.com
  Twitter
  https//twitter.com/BharatBook
  Blog http//www.bharatbook.com/mar
  ket-reports-blog/